Anthem Biosciences Profile
Key Indicators
- Authorised Capital ₹ 125.00 Cr
as on 06-10-2024
- Paid Up Capital ₹ 114.10 Cr
as on 06-10-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 439.71 Cr
as on 06-10-2024
- Satisfied Charges ₹ 280.38 Cr
as on 06-10-2024
- Revenue -11.40%
(FY 2023)
- Profit -5.00%
(FY 2023)
- Ebitda -24.14%
(FY 2023)
- Net Worth 28.49%
(FY 2023)
- Total Assets 23.09%
(FY 2023)
About Anthem Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 125.00 Cr and a paid-up capital of Rs 114.10 Cr.
The company currently has active open charges totaling ₹439.71 Cr. The company has closed loans amounting to ₹280.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Anthem Biosciences Private Limited India are Mohammed Baig as CFO and Divya Prasad as Company Secretary. Ajay Bhardwaj, Ganesh Sambasivam, K Chandrappa, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233KA2006PTC039703
- Company No.
039703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2006
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Anthem Biosciences Private Limited offer?
Anthem Biosciences Private Limited offers a wide range of products and services, including Instrument Calibration & Adjustment, Calibration Services, Testing & Measuring Equipments, Civil Engineering Test Equipment, Pharmaceutical Services, Molecular Biology Services, Laboratory Testing Services, Testing Laboratories, School & College Interior Designers, Library Interior Designing.
Who are the key members and board of directors at Anthem Biosciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Bhardwaj  | Managing Director | 13-Jun-2006 | Current |
| Mohammed Baig | CFO | 01-Apr-2023 | Current |
| Divya Prasad | Company Secretary | 21-Sep-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Sambasivam | Director | 04-Aug-2006 | Current |
| K Chandrappa | Director | 27-Sep-2006 | Current |
| Satish Subbanna | Nominee Director | 09-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of Anthem Biosciences.
Anthem Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.4% decrease. The company also saw a slight decrease in profitability, with a 5% decrease in profit. The company's net worth Soared by an impressive increase of 28.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anthem Biosciences?
In 2023, Anthem Biosciences had a promoter holding of 76.84% and a public holding of 23.16%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neoanthem Lifesciences Private LimitedActive 4 years 4 monthsAjay Bhardwaj, Ganesh Sambasivam and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Feb 2023 | ₹204.00 Cr | Open |
Citi Bank N.A. Creation Date: 15 Sep 2022 | ₹125.00 Cr | Open |
Hdfc Bank Limited Creation Date: 16 May 2017 | ₹25.00 Cr | Open |
How Many Employees Work at Anthem Biosciences?
Anthem Biosciences has a workforce of 1777 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anthem Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anthem Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
